The role of newly diagnosed diabetes mellitus for poor in-hospital prognosis of coronary artery bypass grafting

Background: The management of coronary artery disease in patients with type 2 diabetes (T2DM) who need myocardial revascularization is a great challenge.

Aims: To study the role of newly diagnosed T2DM in the development of in-hospital adverse outcomes after coronary artery surgery (CABG).

Methods: 708 consecutive patients underwent CABG were included. All patients without history of T2DM and with border fasting hyperglycemia underwent an oral glucose tolerance test.

Results: The screening allowed to diagnose T2DM in 8.9% and prediabetes in 10.4% of the study population. The the number of patients with T2DM increased from 15.2% to 24.1%, and with prediabetes from 3.0% to 13.4%. The total number of patients with carbohydrate metabolism disorders increased from 18.2% to 37.5%. The trend towards higher rate of in-hospital complications after CABG was defined among patients with newly diagnosed and previously diagnosed T2DM. The regression analysis demonstrated the presence of the relationships between the previously diagnosed T2DM and the total number of significant complications (odds ratio (OR) 1.350, 95% confidence interval (CI): 1.057–1.723, p=0.020) and prolonged in-hospital stay (OR 1.609, 95%CI 1.202–2.155, p=0.001). The significance of these relationships increased with the addition of newly diagnosed T2DM to the regression model (for in-hospital complications: OR 1.731, 95% CI 1.131–2.626, p=0.012; for prolonged in-hospital stay: OR 2.229, 95%CI 1.412–3.519, p<0.001). Moreover, additional associations between T2DM and the risk of developing multiple organ dysfunction (OR 2.911, 95% CI 1.072–7.901, p=0.039), urgent lower extremity surgery (OR 1.638, 95%CI 1.009–15.213, p=0.020) and the need for extracorporeal correction of hemostasis (OR 3.472, 95%CI 1.042–11.556, p=0.044) have been defined. Importantly, the presence of these associations would not have been identified without including newly diagnosed DM in the regression model.

Conclusion: The newly diagnosed T2DM affects the prognosis of CABG as well as the previously diagnosed T2DM. The obtained results suggest the importance of active preoperative T2DM screening.

coronary artery bypass, myocardial revascularization, newly diagnosed type 2 diabetes mellitus, preoperative status, screening of carbohydrate metabolism disorders, hospital adverse outcomes

1. Ryden L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34(39):3035-3087. doi: 10.1093/eurheartj/eht108

2. Bezdenezhnykh NA, Sumin AN, Bezdenezhnykh AV, Barbarash OL. Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus: A Cardiologist’s View. In: Aronow WS, editor. Coronary Artery Bypass Graft Surgery. London: IntechOpen; 2017. p. 69-88. doi: 10.5772/intechopen.70416

3. Безденежных Н.А., Сумин А.Н. Реваскуляризация миокарда у пациентов с ишемической болезнью сердца при сахарном диабете 2 типа // Сахарный диабет. – 2016. – Т. 19. – №6. – С. 471-478. [Bezdenezhnykh NA, Sumin AN. Myocardial revascularization in patients with coronary heart disease and type 2 diabetes. Diabetes mellitus. 2016;19(6):471-478. (In Russ.)] doi: 10.14341/DM7922

4. Сумин А.Н., Безденежных Н.А., Безденежных А.В., и др. Факторы, ассоциированные с непосредственными результатами коронарного шунтирования у больных ишемической болезнью сердца при наличия сахарного диабета 2 типа // Кардиология. – 2016. – №10. – С. 13-21. [Sumin AN, Bezdenezhnyh NA, Bezdenezhnyh AV, et al. Factors associated with immediate results of coronary artery bypass grafting in patients with ischemic heart disease in the presence of type 2 diabetes. Kardiologiia. 2016;(10):13-21. (In Russ.)] doi: 10.18565/cardio.2016.10.13-21

5. Holzmann MJ, Rathsman B, Eliasson B, et al. Long-term prognosis in patients with type 1 and 2 diabetes mellitus after coronary artery bypass grafting. J Am Coll Cardiol. 2015;65(16):1644-1652. doi: 10.1016/j.jacc.2015.02.052

6. D'Agostino RS, Jacobs JP, Badhwar V, et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2016 Update on Outcomes and Quality. Ann Thorac Surg. 2016;101(1):24-32. doi: 10.1016/j.athoracsur.2015.11.032

7. de la Hera JM, Delgado E, Hernandez E, et al. Prevalence and outcome of newly detected diabetes in patients who undergo percutaneous coronary intervention. Eur Heart J. 2009;30(21):2614-2621. doi: 10.1093/eurheartj/ehp278

8. Balakrishnan R, Berger JS, Tully L, et al. Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention. Diabetes Metab Res Rev. 2015;31(6):603-609. doi: 10.1002/dmrr.2646

9. Petursson P, Herlitz J, Lindqvist J, et al. Prevalence and severity of abnormal glucose regulation and its relation to long-term prognosis after coronary artery bypass grafting. Coron Artery Dis. 2013;24(7):577-582. doi: 10.1097/MCA.0b013e3283645c94

10. Giraldez RR, Clare RM, Lopes RD, et al. Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome. Am Heart J. 2013;165(6):918-925 e912. doi: 10.1016/j.ahj.2013.01.005

11. Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION) // Сахарный диабет. – 2016. – Т. 19. – №2. – С. 104-112. [Dedov II, Shestakova MV, Galstyan GR. The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study). Diabetes Mellitus. 2016;19(2):104-112. (In Russ)] doi: 10.14341/DM2004116-17

12. Дедов И.И., Шестакова М.В., Александров А.А., и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом (5-й выпуск) // Сахарный диабет. – 2011. – Т. 14. – №3S. – C. 2-72. [Dedov II, Shestakova MV, Aleksandrov AA, et al. Algorithms for specialized medical care to patients with diabetes, 5th ed. Diabetes Mellitus. 2011;14(3S):2-72. (In Russ.)] doi: 10.14341/2072-0351-5612

13. Шестакова М.В., Чазова И.Е., Шестакова Е.А. Российское многоцентровое скрининговое исследование по выявлению недиагностированного сахарного диабета 2 типа у пациентов с сердечно-сосудистой патологией // Сахарный диабет. – 2016. – Т. 19. – №1. – С. 24-29. [Shestakova МV, Chazova IE, Shestakova EA. Russian multicentre type 2 diabetes screening program in patients with cardiovascular disease. Diabetes Mellitus. 2016;19(1):24-29. (In Russ.)] doi: 10.14341/DM7765

14. Ritsinger V, Tanoglidi E, Malmberg K, et al. Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort. Diab Vasc Dis Res. 2015;12(1):23-32. doi: 10.1177/1479164114551746

15. Pararajasingam G, Hofsten DE, Logstrup BB, et al. Newly detected abnormal glucose regulation and long-term prognosis after acute myocardial infarction: Comparison of an oral glucose tolerance test and glycosylated haemoglobin A1c. Int J Cardiol. 2016;214:310-315. doi: 10.1016/j.ijcard.2016.03.199

16. Kowalczyk J, Mazurek M, Zielinska T, et al. Prognostic significance of HbA1c in patients with AMI treated invasively and newly detected glucose abnormalities. Eur J Prev Cardiol. 2015;22(6):798-806. doi: 10.1177/2047487314527850

17. Тепляков А.Т., Гракова Е.В., Сваровская А.В., и др. Эффективность эндоваскулярной коронарной реваскуляризации у больных ибс со сниженной фракцией выброса левого желудочка, ассоциированной с сахарным диабетом 2 типа: результаты пятилетного проспективного наблюдения // Комплексные проблемы сердечно-сосудистых заболеваний. – 2017. – №1. – С. 79-91. [Teplyakov AT, Grakova EV, Svarovskaya AV, et al. Efficacy of endovascular coronary revascularization in patients with chd with reduced left ventricular. Complex Issues of Cardiovascular Diseases. 2017;(1):79-91. (In Russ.)] doi: 10.17802/2306-1278-2017-1-79-91

18. Lauruschkat AH, Arnrich B, Albert AA, et al. Prevalence and risks of undiagnosed diabetes mellitus in patients undergoing coronary artery bypass grafting. Circulation. 2005;112(16):2397-2402. doi: 10.1161/CIRCULATIONAHA.105.534545

19. Halkos ME, Lattouf OM, Puskas JD, et al. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery. Ann Thorac Surg. 2008;86(5):1431-1437. doi: 10.1016/j.athoracsur.2008.06.078

20. Tennyson C, Lee R, Attia R. Is there a role for HbA1c in predicting mortality and morbidity outcomes after coronary artery bypass graft surgery? Interact Cardiovasc Thorac Surg. 2013;17(6):1000-1008. doi: 10.1093/icvts/ivt351

21. Zheng J, Cheng J, Wang T, et al. Does HbA1c Level Have Clinical Implications in Diabetic Patients Undergoing Coronary Artery Bypass Grafting? A Systematic Review and Meta-Analysis. Int J Endocrinol. 2017;2017:1537213. doi: 10.1155/2017/1537213

22. Narayan P, Kshirsagar SN, Mandal CK, et al. Preoperative Glycosylated Hemoglobin: A Risk Factor for Patients Undergoing Coronary Artery Bypass. Ann Thorac Surg. 2017;104(2):606-612. doi: 10.1016/j.athoracsur.2016.12.020

23. Wang TK, Woodhead A, Ramanathan T, Pemberton J. Relationship Between Diabetic Variables and Outcomes After Coronary Artery Bypass Grafting in Diabetic Patients. Heart Lung Circ. 2017;26(4):371-375. doi: 10.1016/j.hlc.2016.05.117

24. Безденежных Н.А., Сумин А.Н., Барбараш О.Л. Пациент с сахарным диабетом и реваскуляризация миокарда с позиций доказательной медицины: взгляд кардиолога. Часть 1 // Российский кардиологический журнал. – 2017. – №4. – С. 105-113. [Bezdenezhnykh NA, Sumin AN, Barbarash OL. Patients with diabetes and myocardial revascularization from evidence-based medicine positions: cardiologist’s opinion. Part 1. Russian Journal of Cardiology. 2017;(4):105-113. (In Russ.)] doi: 10.15829/1560-4071-2017-4-105-113

25. Phan K, Mitchell P, Liew G, et al. Severity of coronary artery disease and retinal microvascular signs in patients with diagnosed versus undiagnosed diabetes: cross-sectional study. J Thorac Dis. 2016;8(7):1532-1539. doi: 10.21037/jtd.2016.05.61